Assessment of Suspected Intracranial Malignancy Using 3'-Deoxy-3'18 F-flourothymidine PET

University of Oklahoma13 enrolled

Overview

The primary objective of this study is to detect and quantify tumor cells of high grade malignant gliomas and metastatic brain lesions both before and after initial surgical resection in a cohort of newly diagnosed patients.

In this study, 35 patients will be selected to undergoing sequential imaging with FLT-PET. Prior to surgical resection, patients will undergo a preliminary FLT-PET. Additional FLT scans for a maximum of four scans.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Brain Tumor

Interventions

FLT-PET scanPROCEDURE

Imaging test

Eligibility

Sex: ALLMin age: 18 YearsMax age: 99 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 18 years or older * Women must not be pregnant or breast feeding * Histologic or strong radiologic suspicion of high grade malignant glioma or ogliometastatic tumor(s) Exclusion Criteria: * May not have received previous therapy for their malignancy

Locations (1)

University Of Oklahoma Health Sciences Center

Oklahoma City, Oklahoma, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.